| P50 | author | Spencer B. Gibson | Q39783071 |
| P2093 | author name string | James B Johnston | |
| | Denis Soulières | |
| | Lawrence Panasci | |
| | Raquel Aloyz | |
| | Lilian Amrein | |
| P2860 | cites work | Chronic lymphocytic leukaemia: the nature of the leukaemic cell | Q33368346 |
| | Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis | Q33714786 |
| | Chronic lymphocytic leukemia and treatment resistance in cancer: the role of the p53 pathway | Q37355522 |
| | p53-mediated apoptosis of CLL cells: evidence for a transcription-independent mechanism | Q44510589 |
| | Imatinib sensitizes CLL lymphocytes to chlorambucil | Q44719681 |
| | Dasatinib induces a response in chronic lymphocytic leukemia. | Q46170691 |
| | DNA-dependent protein kinase is a therapeutic target and an indicator of poor prognosis in B-cell chronic lymphocytic leukemia. | Q46535643 |
| | Dasatinib sensitizes primary chronic lymphocytic leukaemia lymphocytes to chlorambucil and fludarabinein vitro | Q58436764 |
| | p53 dysfunction in B-cell chronic lymphocytic leukemia: inactivation of ATM as an alternative to TP53 mutation | Q63384029 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| | lymphocyte | Q715347 |
| | chronic lymphocytic leukemia | Q1088156 |
| | dasatinib | Q419940 |
| | dasatinib monohydrate | Q27139135 |
| P304 | page(s) | 396-398 | |
| P577 | publication date | 2009-09-02 | |
| P1433 | published in | British Journal of Haematology | Q4970200 |
| P1476 | title | Primary del 17 chronic lymphocytic leukaemia lymphocytes are hypersensitive to dasatinib in vitro | |
| P478 | volume | 147 | |